SAIF, Muhammad Wasif. U.S. Food and Drug Administration Approves Paclitaxel Protein-Bound Particles (Abraxane®) in Combination with Gemcitabine as First-Line Treatment of Patients with Metastatic Pancreatic Cancer. JOP. Journal of the Pancreas, [S. l.], v. 14, n. 6, p. 686–688, 2013. DOI: 10.6092/1590-8577/2028. Disponível em: https://serena.sharepress.it/index.php/jop/article/view/2028. Acesso em: 3 may. 2025.